Continuity of care, medication adherence, and health care outcomes among patients with newly diagnosed type 2 diabetes: A longitudinal analysis

Medical Care

Volumn 51, Issue 3, 2013, Pages 231-237

  Chen, Chi Chen ^a   Tseng, Chin Hsiao ^a,b,c   Cheng, Shou Hsia ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

continuity of care; health care outcomes; medication adherence; type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; BIGUANIDE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; ORAL ANTIDIABETIC AGENT; SULFONAMIDE; UREA DERIVATIVE;

ADULT; ARTICLE; FEMALE; FOLLOW UP; HEALTH INSURANCE; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; AGED; CONTINUITY OF PATIENT CARE; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROPENSITY SCORE; QUALITY INDICATORS, HEALTH CARE; REGRESSION ANALYSIS; TAIWAN; TREATMENT OUTCOME;

EID: 84874118540     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31827da5b9     Document Type: Article

References (50)

1. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412.
2. American Diabetes Association. Economic costs of diabetes in the U.S. In 2007. Diabetes Care. 2008;31:596-615.
3. Bureau of National Health Insurance. The 2009 Report of National Health Insurance Annual Statistical Report [in Chinese]. Taiwan: Bureau of National Health Insurance; 2010.
4. Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ. 2007;33:1014-1029.
5. Saultz JW, Lochner J. Interpersonal continuity of care and care outcomes: a critical review. Ann Fam Med. 2005;3:159-166.
6. Van Walraven C, Oake N, Jennings A, et al. The association between continuity of care and outcomes: a systematic and critical review. J Eval Clin Pract. 2010;16:947-956.
7. Koopman RJ, Mainous AG III, Baker R, et al. Continuity of care and recognition of diabetes, hypertension, and hypercholesterolemia. Arch Intern Med. 2003;163:1357-1361.
8. Knight JC, Dowden JJ, Worrall GJ, et al. Does higher continuity of family physician care reduce hospitalizations in elderly people with diabetes? Popul Health Manag. 2009;12:81-86.
9. Lin W, Huang IC, Wang SL, et al. Continuity of diabetes care is associated with avoidable hospitalizations: evidence from Taiwan's National Health Insurance scheme. Int J Qual Health Care. 2010;22: 3-8.
10. Hong JS, Kang HC, Kim J. Continuity of care for elderly patients with diabetes mellitus, hypertension, asthma, and chronic obstructive pulmonary disease in Korea. J Korean Med Sci. 2010;25: 1259-1271.
11. Liu CW, Einstadter D, Cebul RD. Care fragmentation and emergency department use among complex patients with diabetes. Am J Manag Care. 2010;16:413-420.
12. Chen CC, Cheng SH. Better continuity of care reduces costs for diabetic patients. Am J Manag Care. 2011;17:420-427.
13. Hänninen J, Takala J, Keinänen-Kiukaanniemi S. Good continuity of care may improve quality of life in type 2 diabetes. Diabetes Res Clin Pract. 2001;51:21-27.
14. Saultz JW. Defining and measuring interpersonal continuity of care. Ann Fam Med. 2003;1:134-143.
15. Donaldson MS. Continuity of care: a re-conceptualization. Med Care Res Rev. 2001;58:255-290.
16. Charney E, Bynum R, Eldredge D, et al. How well do patients take oral penicillin? A collaborative study in private practice. Pediatrics. 1967;40:188-195.
17. Kerse N, Buetow S, Mainous AG III, et al. Physician-patient relationship and medication compliance: a primary care investigation. Ann Fam Med. 2004;2:455-461.
18. Robles S, Anderson GF. Continuity of care and its effect on prescription drug use among Medicare beneficiaries with hypertension. Med Care. 2011;49:516-521.
19. Hearnshaw H, Lindenmeyer A. What do we mean by adherence to treatment and advice for living with diabetes? A review of the literature on definitions and measurements. Diabet Med. 2006;23: 720-728.
20. Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33:74-109.
21. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing. Associations with medication and medical utilization and spending and health. JAMA. 2007;298:61-69.
22. Gibson TB, Song X, Alemayehu B, et al. Cost sharing, adherence, and health outcomes in patients with diabetes. Am J Manag Care. 2010;16:589-600.
23. Choudhry NK, Fischer MA, Avorn J, et al. At Pitney Bowes, valuebased insurance design cut copayments and increased drug adherence. Health Aff (Millwood). 2010;29:1995-2001.
24. Wen CP, Tsai SP, Chung WS. A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Ann Intern Med. 2008;148:258-267.
25. Cheng TM. Taiwan's new national health insurance program: genesis and experience so far. Health Aff (Millwood). 2003;22:61-76.
26. Chen TJ, Chou LF, Hwang SJ. Patterns of ambulatory care utilization in Taiwan. BMC Health Serv Res. 2006;6:54-61.
27. Fitzmaurice GM, Laird NM, Ware JH. Applied Longitudinal Analysis. Hoboken, NJ: Wiley; 2004.
28. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:S62-S69.
29. Gill JM, Mainous AG, Nsereko M. The effect of continuity of care on emergency department use. Arch Fam Med. 2000;9:333-338.
30. Gill JM, Mainous AG. The role of provider continuity in preventing hospitalizations. Arch Fam Med. 1998;7:352-357.
31. Hong JS, Kang HC. Relationship between oral antihyperglycemic medication adherence and hospitalization, mortality, and healthcare costs in adult ambulatory care patients with type 2 diabetes in South Korea. Med Care. 2011;49:378-384.
32. Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27:2149-2153.
33. Jee SH, Cabana MD. Indices for continuity of care: a systematic review of the literature. Med Care Res Rev. 2006;63:158-188.
34. Breslau N, Reeb KG. Continuity of care in a university-based practice. J Med Educ. 1975;50:965-969.
35. Bice TW, Boxerman SB. A quantitative measure of continuity of care. Med Care. 1977;15:347-349.
36. Steinwachs DM. Measuring provider continuity in ambulatory care: an assessment of alternative approaches. Med Care. 1979;17:551-565.
37. Smedby O, Eklund G, Eriksson EA, et al. Measures of continuity of care. A register-based correlation study. Med Care. 1986;24:511-518.
38. Hepke KL, Martus MT, Share DA. Costs and utilization associated with pharmaceutical adherence in a diabetic population. Am J Manag Care. 2004;10:144-151.
39. Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-530.
40. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836-1841.
41. Karve S, Cleves MA, Helm M, et al. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care. 2008;46:1125-1133.
42. WHO. Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2012. Available at: http://www.whocc.no/atc-ddd-index/. Accessed August 29, 2012.
43. Young BA, Lin E, Von Korff M, et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care. 2008;14:15-23.
44. Meduru P, Helmer D, Rajan M, et al. Chronic illness with complexity: implications for performance measurement of optimal glycemic control. J Gen Intern Med. 2007;22:408-418.
45. Cheng SH, Lee TT, Chen CC. A longitudinal examination of a pay-forperformance program for diabetes care. Evidence from a natural experiment. Med Care. 2012;50:109-116.
46. Huang P, Hsu YH, Kai-Yuan T, et al. Can European external peer review techniques be introduced and adopted into Taiwan's hospital accreditation system? Int J Qual Health Care. 2000;12:251-254.
47. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173-1182.
48. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
49. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27:1218-1224.
50. Steiner JF. Can we identify clinical predictors of medication adherencey and should we? Med Care. 2010;48:193-195.